133 related articles for article (PubMed ID: 36192179)
1. Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy: Case Study.
Forrest SL; Tartaglia MC; Kim A; Alcaide-Leon P; Rogaeva E; Lang A; Kovacs GG
Neurology; 2022 Dec; 99(24):1094-1098. PubMed ID: 36192179
[TBL] [Abstract][Full Text] [Related]
2. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
3. Protracted course progressive supranuclear palsy.
Couto B; Martinez-Valbuena I; Lee S; Alfradique-Dunham I; Perrin RJ; Perlmutter JS; Cruchaga C; Kim A; Visanji N; Sato C; Rogaeva E; Lang AE; Kovacs GG
Eur J Neurol; 2022 Aug; 29(8):2220-2231. PubMed ID: 35384155
[TBL] [Abstract][Full Text] [Related]
4. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
Kowalska A; Jamrozik Z; Kwieciński H
Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
[TBL] [Abstract][Full Text] [Related]
5. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
6. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
[TBL] [Abstract][Full Text] [Related]
7. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
9. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
[TBL] [Abstract][Full Text] [Related]
10. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
[TBL] [Abstract][Full Text] [Related]
11. The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features.
Badihian N; Ali F; Botha H; Savica R; Machulda MM; Clark HM; Stierwalt JAG; Pham NTT; Baker MC; Rademakers R; Lowe V; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2024 Feb; 119():105962. PubMed ID: 38134678
[TBL] [Abstract][Full Text] [Related]
12. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report].
Morishima R; Bandoh M; Sunami Y; Isozaki E
Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
14. The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.
Camuzat A; Romana M; Dürr A; Feingold J; Brice A; Ruberg M; Lannuzel A
Mov Disord; 2008 Dec; 23(16):2384-91. PubMed ID: 18785640
[TBL] [Abstract][Full Text] [Related]
15. [Progressive supranuclear palsy; an unusual form of parkinsonism].
Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
Koizumi R; Akagi A; Riku Y; Sone J; Miyahara H; Tanaka F; Yoshida M; Iwasaki Y
Neuropathology; 2023 Jun; 43(3):233-243. PubMed ID: 36222051
[TBL] [Abstract][Full Text] [Related]
17. DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy.
Honda H; Sasagasako N; Shen C; Shijo M; Hamasaki H; Suzuki SO; Tsuboi Y; Fujii N; Iwaki T
Parkinsonism Relat Disord; 2018 Jun; 51():105-110. PubMed ID: 29499916
[TBL] [Abstract][Full Text] [Related]
18. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
19. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
[TBL] [Abstract][Full Text] [Related]
20. An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
Suzuki Y; Adachi T; Sakuwa M; Sakata R; Takigawa H; Hasegawa M; Hanajima R
Neuropathology; 2022 Oct; 42(5):447-452. PubMed ID: 35811445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
